Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Clinical trial NCT02834390 · COMPLETED
Trial details
- NCT number
- NCT02834390
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-12
- Primary completion
- 2017-10-19
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.